Scientific Oath 🙋🏻‍♂️.I promise to work for a better world, where science and technology are used in socially responsible ways. I will not use my education for any purpose intended to harm human beings or the environment. 1/2.

📢📢 Oficialmente, las guías 2024 del ACR para nefritis lúpica disponibles en extenso!!.

Join millions who have switched to Grok.

I wasn't expecting this! 😮.Shout-out to @MariaCuellarMD, @AliDuarteMD, and all the team!.

📢📢📢Check out the new 2024 ACR Guideline for the Screening, Treatment, and Management of Lupus Nephritis!!! .Now available online:

RT @mugartegil: 🚨🆕paper: #hypertension predicts #global and #renal #damage in #SLE #lupus data from the #AlmenaraLupusCohort @cientifica_su….

RT @JaimeFG_MD: 🚨New Research Alert 🚨 . Excited to share our latest study in @TheLancetRheum . We analyzed the accuracy, quality, and safet….

RT @jasonsknight: Antiphospholipid Antibodies Linked to Increased Risk for Diffuse Alveolar Hemorrhage in SLE

@lain_sanchez @JoseMeadeMD @marianagt95 @MariaCuellarMD @CDCChronic @MayoGradSchool @RochesterEpi.

This study is derived from my master’s degree thesis. I would like to thank my mentors @AliDuarteMD, @CrowsonCindy, and my TAC: Matthew J. Koster, MD, @LadanZand, and @mugartegil. Also, thanks to all coauthors and funding sources that made this project possible.

6/6 📝 Conclusion: While the ominosity score shows promise for predicting mortality, it’s not significantly better than using age and sex alone. Further research is essential to enhance prediction tools for SLE outcomes. #LupusAwareness #ResearchContinues.

5/6 🔍 Key Finding #3: The ominosity score included factors like age, sex, thrombocytopenia, neuropsychiatric manifestations, and more, highlighting the complexity of SLE manifestations. #ClinicalFactors.

4/6 📉 Key Finding #2: The model for predicting hospitalization performed poorly, with a concordance of only 0.52, suggesting that more work is needed to accurately predict hospitalizations in SLE patients. #HospitalizationRisk.

3/6 📊 Key Finding #1: The ominosity score for mortality showed a concordance of 0.76, indicating good predictive performance, but it didn’t outperform a simpler model using just age, sex, and calendar year (concordance of 0.77). #PredictiveModeling.

2/6 🧐 Main Objective: The study aimed to evaluate the 2019 EULAR/ACR SLE score as a predictor for mortality and hospitalization, and to develop a new ominosity score based on these criteria. #ResearchGoals.

🧵 1/6 New research alert! 🚨 Our most recent LUMEN (💡) paper explores the utility of the 2019 EULAR/ACR SLE classification criteria in predicting mortality and hospitalization in patients with SLE. #LupusResearch #SLE.

Happy to share our most recent review on glucocorticoids in patients with #lupus #nephritis! Thanks to @NDTsocial for publishing our work. @AliDuarteMD, Erika Navarro, Mario Bautista.

RT @ACRheum: In a new summary of its 2024 Guideline for the Screening, Treatment, and Management of Lupus Nephritis, the ACR offers 41 reco….

RT @EBRheum: All-caps abstract text throw-down by Michelle Petri re:fractures in SLE 😆 . I keep saying this; our obsesssion with vitamin d….

RT @jasonsknight: Talked a little #antiphospholipid history 🧐 before the forward-looking bits 🔮 #ACR24

RT @EBRheum: Happening now, new guidelines for mgmt. A few highlights: . Recommend prompt GC therapy, pulse x1-3d followed by oral pred (<0….

RT @MithuRheum: 🆕 #ACR24 | Updated Guidelines for Lupus Nephritis Treatment & Management 🫘. Highlights 🔶 .• Critical role of renal biopsy.•….